Should we wait or not?: The preferable option for patients with stage IV oral cancer in COVID-19 pandemic

Abstract

Background
The coronavirus infection is rapidly spreading, putting a strain on health care services across the globe. Patients with oral cancer are susceptible often immunosuppressed due to the disease and/or the treatment received.
Methods
We performed a simulation of the currently available data using a multistate and hazards model to provide an objective model for counseling and decision making for health care workers.
Results
Stage IV patients with oral cancer who did not receive treatment had progression of disease and an increased mortality rate compared to patients who receive treatment but did not contract COVID-19. The patients who received treatment and got affected with COVID-19 had a far worse impact and higher mortality rate than all other groups.
Conclusion
Isolation and deferring treatment for stage IV patients with oral cancer, so as to avoid hospital visits and contraction of COVID-19, is an advisable strategy based on this model.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Downloadable citations

Identifiers

DOI

https://doi.org/10.1002/hed.26196

Repository URI

https://discovery.dundee.ac.uk/en/publications/2ec1d78a-1908-472c-ad4c-449e865aa6df